Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

Similar articles for PubMed (Select 17663539)

1.

Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.

Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, Lee CK, Chang ST, Kuo CJ, Lee SS, Hou CC, Hsiao PW, Chien SC, Shyur LF, Yang NS.

J Med Chem. 2007 Aug 23;50(17):4087-95. Epub 2007 Jul 31.

PMID:
17663539
2.

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

Hsu JT, Kuo CJ, Hsieh HP, Wang YC, Huang KK, Lin CP, Huang PF, Chen X, Liang PH.

FEBS Lett. 2004 Sep 10;574(1-3):116-20.

PMID:
15358550
3.
4.

Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor.

Yang S, Chen SJ, Hsu MF, Wu JD, Tseng CT, Liu YF, Chen HC, Kuo CW, Wu CS, Chang LW, Chen WC, Liao SY, Chang TY, Hung HH, Shr HL, Liu CY, Huang YA, Chang LY, Hsu JC, Peters CJ, Wang AH, Hsu MC.

J Med Chem. 2006 Aug 10;49(16):4971-80.

PMID:
16884309
5.

Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.

Tsai KC, Chen SY, Liang PH, Lu IL, Mahindroo N, Hsieh HP, Chao YS, Liu L, Liu D, Lien W, Lin TH, Wu SY.

J Med Chem. 2006 Jun 15;49(12):3485-95.

PMID:
16759091
6.

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.

Chen L, Gui C, Luo X, Yang Q, G√ľnther S, Scandella E, Drosten C, Bai D, He X, Ludewig B, Chen J, Luo H, Yang Y, Yang Y, Zou J, Thiel V, Chen K, Shen J, Shen X, Jiang H.

J Virol. 2005 Jun;79(11):7095-103.

7.

Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.

Goetz DH, Choe Y, Hansell E, Chen YT, McDowell M, Jonsson CB, Roush WR, McKerrow J, Craik CS.

Biochemistry. 2007 Jul 31;46(30):8744-52. Epub 2007 Jul 3.

PMID:
17605471
8.

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.

Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I.

Antiviral Res. 2005 Jun;66(2-3):159-63. Epub 2005 Feb 19.

PMID:
15911031
9.

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

Kao RY, Tsui WH, Lee TS, Tanner JA, Watt RM, Huang JD, Hu L, Chen G, Chen Z, Zhang L, He T, Chan KH, Tse H, To AP, Ng LW, Wong BC, Tsoi HW, Yang D, Ho DD, Yuen KY.

Chem Biol. 2004 Sep;11(9):1293-9.

PMID:
15380189
10.

Identification of natural compounds with antiviral activities against SARS-associated coronavirus.

Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X.

Antiviral Res. 2005 Jul;67(1):18-23.

PMID:
15885816
11.

Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication.

Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y.

Eur J Med Chem. 2006 Sep;41(9):1084-9. Epub 2006 Jul 27.

PMID:
16875760
12.

Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).

Chu CK, Gadthula S, Chen X, Choo H, Olgen S, Barnard DL, Sidwell RW.

Antivir Chem Chemother. 2006;17(5):285-9.

PMID:
17176633
13.

Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.

Yang Q, Chen L, He X, Gao Z, Shen X, Bai D.

Chem Pharm Bull (Tokyo). 2008 Oct;56(10):1400-5.

14.

Indomethacin has a potent antiviral activity against SARS coronavirus.

Amici C, Di Coro A, Ciucci A, Chiappa L, Castilletti C, Martella V, Decaro N, Buonavoglia C, Capobianchi MR, Santoro MG.

Antivir Ther. 2006;11(8):1021-30.

PMID:
17302372
15.

Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.

Lin CW, Tsai CH, Tsai FJ, Chen PJ, Lai CC, Wan L, Chiu HH, Lin KH.

FEBS Lett. 2004 Sep 10;574(1-3):131-7.

PMID:
15358553
16.

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.

Lu IL, Mahindroo N, Liang PH, Peng YH, Kuo CJ, Tsai KC, Hsieh HP, Chao YS, Wu SY.

J Med Chem. 2006 Aug 24;49(17):5154-61.

PMID:
16913704
17.

Variation analysis of the severe acute respiratory syndrome coronavirus putative non-structural protein 2 gene and construction of three-dimensional model.

Lu JH, Zhang DM, Wang GL, Guo ZM, Zhang CH, Tan BY, Ouyang LP, Lin L, Liu YM, Chen WQ, Ling WH, Yu XB, Zhong NS.

Chin Med J (Engl). 2005 May 5;118(9):707-13.

PMID:
15899130
18.

Small molecules targeting severe acute respiratory syndrome human coronavirus.

Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, Hsu HH, Huang HC, Wu D, Brik A, Liang FS, Liu RS, Fang JM, Chen ST, Liang PH, Wong CH.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7. Epub 2004 Jun 28.

19.

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.

Shie JJ, Fang JM, Kuo CJ, Kuo TH, Liang PH, Huang HJ, Yang WB, Lin CH, Chen JL, Wu YT, Wong CH.

J Med Chem. 2005 Jun 30;48(13):4469-73.

PMID:
15974598
20.

Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.

Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, Chan PK, Sidwell RW.

Antivir Chem Chemother. 2006;17(5):275-84.

PMID:
17176632
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk